Results 21 to 30 of about 77,446 (306)

Colchicine-Binding Site Inhibitors from Chemistry to Clinic: A Review

open access: yesPharmaceuticals, 2020
It is over 50 years since the discovery of microtubules, and they have become one of the most important drug targets for anti-cancer therapies. Microtubules are predominantly composed of the protein tubulin, which contains a number of different binding ...
Eavan C. McLoughlin, Niamh M. O’Boyle
semanticscholar   +1 more source

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

open access: yesNew England Journal of Medicine, 2019
BACKGROUND Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.
J. Tardif   +24 more
semanticscholar   +1 more source

Case Report: Colchicine Toxicokinetic Analysis in a Poisoned Child Requiring Extracorporeal Life Support

open access: yesFrontiers in Pediatrics, 2021
Colchicine poisoning is associated with a poor prognosis, especially when leading to shock and multi-organ failure, and management is limited to supportive care, including multiple-dose activated charcoal.
Maria Pérez Marín   +9 more
doaj   +1 more source

Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) – study protocol for a randomised controlled trial

open access: yesEuropean Stroke Journal, 2021
Background Inflammation contributes to unstable atherosclerotic plaque and stroke. In randomised trials in patients with coronary disease, canukinumab (an interleukin-1B antagonist) and colchicine (a tubulin inhibitor with pleiotropic anti-inflammatory ...
P. Kelly   +24 more
semanticscholar   +1 more source

Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines

open access: yesKaohsiung Journal of Medical Sciences, 2016
Colchicine is a very cheap microtubule destabilizer. Because microtubules are an ideal target for anticancer drugs, the purpose of this study was to investigate whether clinically acceptable colchicine concentrations have anticancer effects on gastric ...
Zu-Yau Lin   +3 more
doaj   +1 more source

Destabilising microtubule polymerization regulates chondrocyte dedifferentiation and inflammation via nuclear factor kappa b and β-catenin pathway

open access: yesBangladesh Journal of Pharmacology, 2023
The role of cell morphological changes in colchicine-inhibited tubulin polymerization of rabbit articular chondrocytes and their involvement in dedifferentiation were investigated.
Yohan Han   +3 more
doaj   +1 more source

Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis

open access: yesClinical and Experimental Pharmacology and Physiology, 2021
Currently, there is no widely acceptable and proven effective treatment for coronavirus disease 2019 (COVID‐19). Colchicine has been shown to offer a benefit in reducing the inflammation in several inflammatory diseases.
T. Hariyanto   +4 more
semanticscholar   +1 more source

COLCHICINE [PDF]

open access: yesThe Journal of Nervous and Mental Disease, 1876
n ...
openaire   +2 more sources

Colchicine in overdose [PDF]

open access: yesBritish Journal of General Practice, 2017
We read with interest the letter from Lloyd warning of the danger of colchicine overdose1 and agree that this can have devastating consequences. However, the …
Christian D Mallen, Edward Roddy
openaire   +3 more sources

Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2021
Discovering of new anticancer agents with potential activity against tubulin polymerisation is still a promising approach. Colchicine binding site inhibitors are the most relevant anti-tubulin polymerisation agents.
Mohamed Hagras   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy